“Cervical cancer, one of Mongolia’s long-standing challenges, to be eliminated through Cerviray”

On March 31, the healthcare AI forum “The 1st ARTIFICIAL INTELLIGENCE in Healthcare” was successfully held in Ulaanbaatar, Mongolia.

Held at THE BLUE SKY HOTEL & TOWER, the forum was co-hosted by the Mongolian National Cancer Center, the Mongolian National University of Medical Sciences, and Adchem. It invited medical and public health professionals and entrepreneurs from Mongolia and Korea, providing an opportunity to exchange information and learn under the theme of “AI in healthcare.”

A total of 10 speakers attended—including Professor Seok Ki-tae (Division of Gastroenterology, Hallym University Chuncheon Sacred Heart Hospital), Professor Kim Ki-dong (Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital), Professor Erdenekhuu N. (Director, Mongolian National Cancer Center), Dr. Bayarsaikhan L. (Medical Advisor, Adchem), and Dr. Bayarbaatar B. (President, Mongolian Medical AI Society)—and discussed the role and importance of AI in healthcare. They also emphasized the importance of early detection of cervical cancer, liver cancer, and gastric cancer through AIDOT’s innovative products, including Cerviray AI, BIO dot AI, and GIGA dot AI.

More than 200 attendees, hoping for healthier and better lives for women, contributed to the event’s success, showing interest in the related products and technologies not only through open discussions and Q&A with the speakers, but also through live demonstrations.

In particular, Mongolia’s lawmaker J. Chinburen said, “AIDOT will enable people in parts of Mongolia with limited access to healthcare to benefit through AI, and will work to eliminate cervical cancer, one of Mongolia’s long-standing challenges, through Cerviray,” expressing strong expectations for the product.

In addition, a representative from AIDOT’s Global Sales & Marketing Team stated, “Cervical cancer is the most common cancer and has a high mortality rate among women aged 15–44 in Mongolia, and we plan to conduct clinical work with the local National Cancer Center and medical staff so that our AI-based cervical cancer reading system, Cerviray, can help improve the health of Mongolian women and be selected for the national cervical cancer screening program.” The representative added, “We will also introduce GIGA dot AI and COLON dot AI, our AI-based real-time upper and lower endoscopy solutions, as well as BIO dot AI, a microbiome-based alcoholic liver disease diagnostic system, and we plan to actively cooperate to eliminate cancer in Mongolia.”